Showing results (221-230 of 237) with videos related to
Sort By:
Pageof 24
Circulation|October 25, 2014
Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correctionJudith A A E Cuypers, Myrthe E Menting, Elisabeth E M Konings, et al.Heart Rhythm O2|November 24, 2025
Proteomic biomarkers and biological pathways associated with atrial fibrillation in heart failure patients with reduced ejection fractionTeun B Petersen, Mylène Barry-Loncq de Jong, Jie Fen Chin, et al.European Journal of Pediatrics|August 20, 2020
Infliximab in young paediatric IBD patients: it is all about the dosingMaria M E Jongsma, Dwight A Winter, Hien Q Huynh, et al.The Lancet. Psychiatry|November 20, 2022
Leaving child and adolescent mental health services in the MILESTONE cohort: a longitudinal cohort study on young people's mental health indicators, care pathways, and outcomes in EuropeSuzanne E Gerritsen, Larissa S van Bodegom, Mathilde M Overbeek, et al.Journal of Pediatric Gastroenterology and Nutrition|September 20, 2023
Gastrointestinal Biomarkers and Their Association with Feeding in the First Five Days of Pediatric Critical IllnessKarlien Veldscholte, Jessie M Hulst, Renate D Eveleens, et al.Clinical and Experimental Medicine|November 11, 2025
Increasing inflammatory biomarkers are associated with mortality in critically ill COVID-19 patients despite anti-inflammatory treatmentKatrijn Daenen, Dimitris Rizopoulos, Virgil A S H Dalm, et al.Journal of Affective Disorders|July 17, 2025
Do young people get the mental healthcare they need? Trajectories of depressive symptoms, correlates and care pathways in a clinical sample of young people reaching the upper age limit of their CAMHSLarissa S van Bodegom, Suzanne E Gerritsen, Athanasios Maras, et al.Blood|August 27, 2013
Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALLArian van der Veer, Esmé Waanders, Rob Pieters, et al.Alimentary Pharmacology & Therapeutics|April 22, 2024
Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's diseaseStephanie A Vuijk, Maria M E Jongsma, Britt M Hoeven, et al.Circulation. Cardiovascular Interventions|July 13, 2021
Endovascular Revascularization Plus Supervised Exercise Versus Supervised Exercise Only for Intermittent Claudication: A Cost-Effectiveness AnalysisFarzin Fakhry, Ellen V Rouwet, Reinier Spillenaar Bilgen, et al.Pageof 24